MEDICAL PROPERTIES TRUST INC
Medical Properties Trust is a self-advised real estate investment trust that acquires and develops healthcare facilities for healthcare operators. It leases properties to operators under long-term net leases, generally requiring tenants to cover most property operating costs. Its facilities include general acute care hospitals, behavioral health facilities, post acute care facilities, and freestanding emergency rooms and urgent care centers. Medical Properties Trust also makes mortgage loans secured by healthcare real estate, provides certain working capital loans through taxable REIT subsidiaries, and holds minority interests in some tenants’ operations. The company makes money primarily from rent, as well as interest on loans and profits or equity interests in certain tenants’ operations. At December 31, 2025, it had investments in 384 facilities across 31 states in the U.S., seven countries in Europe, and Colombia. Medical Properties Trust is headquartered in Birmingham, Alabama.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $MPT in the last 30 days.
See all $MPT insider activity →Medical Properties Trust (MPT) reported Q3 earnings, highlighting cash rental revenue exceeding $1 billion target, strong operator performance, and asset sales gains. Challenges include HSA rent non-payment, Priory rent reduction, and Colombia impairments. Management expects continued growth and refinancing progress.
Medical Properties Trust (MPT) was downgraded from hold to sell due to tenant issues and uncertain recovery, despite low valuation and high yield. Analyst cites persistent non-payments and weak rent coverage as concerns for dividend sustainability, despite balance sheet improvements. Upgrade contingent on reliable rent collections and dividend clarity.
BNP Paribas Exane downgraded Medical Properties Trust (MPT) to Neutral, lowering its price target to $2.25. Concerns include unpaid rent from key tenants and declining financial metrics. MPT's stock is down 20% this week. RBC also downgraded MPT to Underperform, citing tenant issues and liquidity concerns. Q3 earnings beat expectations but revenue missed forecasts.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning MPT (MEDICAL PROPERTIES TRUST INC). Coverage has skewed bearish: 0 bullish, 1 neutral, and 1 bearish.
Recent MPT coverage spans earnings and financial news.
The call reiterates previously released numbers; little new catalyst for price movement.
Downgrade signals increased risk and may trigger sell‑offs.
Analyst downgrade and lower price target likely increase selling pressure.
Mixed impact: asset sale proceeds and refinancing are positive, but rent cuts and loan exposure to HSA create downside risk.
The downgrade and lower price target are likely to generate selling pressure on MPT.
AlphAI scores every news story that mentions MPT with an AI model for sentiment and relevance, and aggregates insider trades from MEDICAL PROPERTIES TRUST INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Medical Properties Trust (MPT) reported Q3 earnings, highlighting cash rental revenue exceeding $1 billion target, strong operator performance, and asset sales gains. Challenges include HSA rent non-payment, Priory rent reduction, and Colombia impairments. Management expects continued growth and refinancing progress.
Medical Properties Trust (MPT) was downgraded from hold to sell due to tenant issues and uncertain recovery, despite low valuation and high yield. Analyst cites persistent non-payments and weak rent coverage as concerns for dividend sustainability, despite balance sheet improvements. Upgrade contingent on reliable rent collections and dividend clarity.
BNP Paribas Exane downgraded Medical Properties Trust (MPT) to Neutral, lowering its price target to $2.25. Concerns include unpaid rent from key tenants and declining financial metrics. MPT's stock is down 20% this week. RBC also downgraded MPT to Underperform, citing tenant issues and liquidity concerns. Q3 earnings beat expectations but revenue missed forecasts.
Medical Properties Trust (MPT) reported Q3 updates, including a 14% increase in HSA hospital volumes and 24% rise in cash collections. The company has $150M loans to HSA, with no rent payment timeline. Priory's rent reduced by 18% due to U.K. NHS funding constraints. MPT recorded $158M gains from asset sales and completed a $2.4B secured-notes transaction. Next refinancing steps include extending its bank revolver and repaying a $200M term loan.
RBC Capital downgraded Medical Properties Trust (MPT) to Underperform, lowering its price target to $2.00 from $4.50, citing tenant issues and liquidity concerns. MPT's stock is down 9.6% over the past week and nearly 50% year-to-date. The company's Q3 2026 earnings beat estimates, but revenue missed expectations, highlighting ongoing tenant challenges.
MPT reported Q3 2026 earnings, exceeding annualized cash rental revenue projections with $750M collected year-to-date. The company sold 9 properties for $600M, expects 2027 portfolio cash rents above $1B. MPT addressed HSA's revenue cycle management challenges by engaging Ovation Healthcare. They also reduced Priory's annual rental obligations by 18% with a 10-year lease extension option.
Medical Properties Trust (MPT) fell 13% after Q3 normalized FFO of $0.11 missed estimates of $0.13, due to tenant HSA's unpaid September rent. Revenue was $250.1M vs. expected $262.5M. MPT's dividend payout ratio is high, and further misses could pressure it. Omega Healthcare Investors (OHI) and Sabra Health Care REIT (SBRA) gained 2%, suggesting MPT's issues may be isolated.
MEDICAL PROPERTIES TRUST INC (MPT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contact: Charles Lambert Senior Vice President of Finance & Treasurer Medical Properties Trust, Inc. (205) 397-8897 clambert@mpt.com MPT REPORTS THIRD QUARTER RESULTS Completed Previously Announced Transactions that Provided Approximately $680 Million in Asset Sale P
Medical Properties (MPT) reported Q3 EPS of $0.34, beating estimates by $0.34, but revenue of $250.14M fell short of expectations. The stock is down 40.6% in 3 months and 46.8% in 12 months. InvestingPro rates its financial health as 'fair performance'.
Medical Properties Trust (MPT) reports Q3 2026 earnings on Oct 22, with analysts expecting $0.0033 EPS on $254.63M revenue. The hospital REIT faces critical test amid tenant bankruptcies and cash flow concerns. Wall Street remains cautious, with an average $5.125 price target. Investors watch for rent collection, profitability, and portfolio updates.
